---
schema_version: "secwatch.filing_event.v1"
accession: "0000917520-22-000044"
form_type: "8-K"
ticker: "IART"
cik: "0000917520"
company_name: "INTEGRA LIFESCIENCES HOLDINGS CORP"
filed_at: "2022-09-23T23:59:59+00:00"
generated_at: "2026-06-23T07:53:28.503393+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Integra LifeSciences enters separation agreement with former COO Glenn Coleman; $1.67M severance

## Summary
- COO position eliminated; separation effective Sept 23, 2022. Severance of $1,668,600 payable in monthly installments over 18 months.
- Coleman remains eligible for 2022 annual bonus based on performance goals, paid on normal senior executive schedule.
- Previously unvested stock options and restricted stock awards fully vest; options exercisable on original schedule through max expiration.
- Performance stock unit awards remain outstanding and eligible to vest upon achievement of performance conditions.
- Two-year non-compete and non-solicit covenants apply; non-disparagement clause included.

## SEC filing metadata
- accession: 0000917520-22-000044
- form_type: 8-K
- ticker: IART
- cik: 0000917520
- company_name: INTEGRA LIFESCIENCES HOLDINGS CORP
- filed_at: 2022-09-23T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/917520/000091752022000044/0000917520-22-000044-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/917520/000091752022000044/iart-20220923.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000917520-22-000044
- JSON: https://secwatch.observer/filing/0000917520-22-000044.json
- Plain text: https://secwatch.observer/filing/0000917520-22-000044.txt

## Key facts
- Executive change
  Glenn Coleman departed as Chief Operating Officer at INTEGRA LIFESCIENCES HOLDINGS CORP.
  - Action: separated
  - Role: Chief Operating Officer
  source text: As previously disclosed, on August 25, 2022, Integra LifeSciences Holdings Corporation (the “Company”) announced the elimination of the position of Chief Operating Officer and the separation of Glenn Coleman, the Company’s Chief Operating Officer, from the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/917520/000091752022000044/0000917520-22-000044-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.